Scholarlink

<p>The 13th Annual EndoBridge Meeting took place in Antalya, Türkiye, from October 23 to 26, 2025. Accredited by the European Council, the congress delivered a comprehensive scientific program combining state-of-the-art lectures with interactive small-group case discussions led by internationally recognized experts in endocrinology and metabolism. The meeting drew a diverse audience and provided an in-depth review of major areas within the field. Core subjects included disorders of the pituitary, thyroid, adrenal glands, and bone metabolism, as well as neuroendocrine tumors, diabetes, obesity, clinical nutrition, and lipid abnormalities. Clinical case abstracts presented in oral and poster sessions were subsequently published in JCEM Case Reports. This report highlights the principal themes and clinical insights shared during the congress. Key discussions addressed contemporary approaches to acromegaly management, therapeutic strategies for subclinical thyroid dysfunction, goal-oriented treatment models in osteoporosis, adjunctive options in type 1 diabetes management, and the evolving concept of obesity phenotyping. Additional updates covered hormonal treatment strategies for menopause and premature ovarian insufficiency, along with recent developments in male hypogonadism and infertility. Overall, the sessions reflected current advances in endocrine science while offering practical guidance for the management of common and complex endocrine disorders. The 14th Annual EndoBridge Meeting will be held in Antalya, Türkiye, from October 22 to 25, 2026.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

EndoBridge 2025: pearls and highlights

  • 期刊论文

  • 发表日期：

    2026年7月20日

查看全文
  • Bulent Okan Yildiz,
  • Mirco Armenti,
  • Maria Luisa Brandi,
  • John Carey,
  • Tobias Carling,
  • Andreea Ciudin,
  • Ketan Dhatariya,
  • Athanasios Fountas,
  • Gema Frühbeck,
  • Dimitrios Goulis,
  • Maria Grammatikopoulou,
  • Mark Gurnell,
  • Gary D. Hammer,
  • Angelica Lindén Hirschberg,
  • Susan Jawad,
  • Jacqueline Jonklaas,
  • Ursula Kaiser,
  • Niki Karavitaki,
  • Aliya Khan,
  • Luka Lezaic,
  • James MacFarlane,
  • Djuro Macut,
  • Julia K. Mader,
  • Barbara McGowan,
  • Dipesh Patel,
  • Athena Philis-Tsimikas,
  • Lena Radić,
  • Mario Salvi,
  • Emily Rose N. San Diego,
  • Heide Siggelkow,
  • Constantine A. Stratakis,
  • Dilek Yazici,
  • Ozlem Celik

摘要

The 13th Annual EndoBridge Meeting took place in Antalya, Türkiye, from October 23 to 26, 2025. Accredited by the European Council, the congress delivered a comprehensive scientific program combining state-of-the-art lectures with interactive small-group case discussions led by internationally recognized experts in endocrinology and metabolism. The meeting drew a diverse audience and provided an in-depth review of major areas within the field. Core subjects included disorders of the pituitary, thyroid, adrenal glands, and bone metabolism, as well as neuroendocrine tumors, diabetes, obesity, clinical nutrition, and lipid abnormalities. Clinical case abstracts presented in oral and poster sessions were subsequently published in JCEM Case Reports. This report highlights the principal themes and clinical insights shared during the congress. Key discussions addressed contemporary approaches to acromegaly management, therapeutic strategies for subclinical thyroid dysfunction, goal-oriented treatment models in osteoporosis, adjunctive options in type 1 diabetes management, and the evolving concept of obesity phenotyping. Additional updates covered hormonal treatment strategies for menopause and premature ovarian insufficiency, along with recent developments in male hypogonadism and infertility. Overall, the sessions reflected current advances in endocrine science while offering practical guidance for the management of common and complex endocrine disorders. The 14th Annual EndoBridge Meeting will be held in Antalya, Türkiye, from October 22 to 25, 2026.